Course Content
Anaemia
Anaemia is defined as a reduction in haemoglobin (Hb) concentration below the normal range, leading to decreased oxygen-carrying capacity of the blood. It is a common condition with various underlying causes, and its recognition and management are essential for UKMLA.
0/13
Transfusion Reactions
Transfusion reactions are adverse events that occur during or after a blood transfusion. Recognising, managing, and preventing these reactions are key for UKMLA.
0/1
Clinical haematology
About Lesson

Hyposplenism refers to reduced or absent splenic function, which leads to impaired immune response and increased susceptibility to infections. Understanding its causes, consequences, and management is essential for UKMLA.

Aetiology:

  1. Congenital:
    • Asplenia or polysplenia syndromes.
  2. Acquired:
    • Splenectomy: Surgical removal of the spleen (e.g., trauma, malignancy).
    • Sickle Cell Disease: Autosplenectomy due to repeated infarctions.
    • Coeliac Disease: Associated with functional hyposplenism.
    • Inflammatory Bowel Disease: Especially Crohn’s disease.
    • Systemic Lupus Erythematosus.
    • HIV/AIDS: Secondary to immune dysfunction.
    • Alcoholic Liver Disease.

Pathophysiology:

  • The spleen plays a crucial role in filtering abnormal red cells and opsonising encapsulated bacteria.
  • Loss of splenic function leads to reduced phagocytosis, complement activation, and antibody production.

Clinical Features:

  1. Asymptomatic:
    • Many patients are asymptomatic and diagnosed during investigations.
  2. Recurrent or Severe Infections:
    • Particularly with encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis).
  3. Thrombocytosis:
    • High platelet count due to loss of splenic sequestration.
  4. Howell-Jolly Bodies:
    • Presence of nuclear remnants in red blood cells on peripheral blood film (indicative of hyposplenism).

Investigations:

  1. Peripheral Blood Film:
    • Howell-Jolly bodies, target cells, acanthocytes.
  2. Full Blood Count (FBC):
    • Thrombocytosis, mild leukocytosis.
  3. Imaging:
    • Ultrasound or CT to assess spleen size and structure.
  4. Functional Tests:
    • Pitted red cell count or scintigraphy for functional assessment (rarely performed in routine practice).

Management:

  1. Prophylactic Vaccination:
    • Vaccines against encapsulated bacteria:
      • Pneumococcal (e.g., PCV13 and PPV23).
      • Meningococcal (e.g., MenACWY, MenB).
      • Haemophilus influenzae type b (Hib).
      • Influenza vaccine annually.
  2. Antibiotic Prophylaxis:
    • Lifelong low-dose penicillin V (especially for splenectomy patients and children).
  3. Patient Education:
    • Awareness of infection risks and seeking prompt medical attention for febrile illness.
  4. Infection Management:
    • Empirical antibiotics for febrile illnesses (e.g., amoxicillin or levofloxacin if penicillin-allergic).
  5. Other Measures:
    • Malaria prophylaxis for travel to endemic areas.
    • Avoidance of animal bites (e.g., risk of Capnocytophaga canimorsus infection).

Complications:

  1. Severe Infections:
    • Overwhelming post-splenectomy infection (OPSI): High mortality, rapid onset sepsis.
  2. Thrombosis:
    • Increased risk of thrombotic events (e.g., deep vein thrombosis, pulmonary embolism).
  3. Haematological:
    • Persistent thrombocytosis, leading to hypercoagulability.

Prognosis:

  • Good with appropriate vaccination and prophylaxis.
  • High risk of life-threatening infections without preventive measures.

Key Exam Points for UKMLA:

  1. Diagnosis:
    • Howell-Jolly bodies on blood film and history of splenectomy or splenic dysfunction.
  2. Infections:
    • High-risk pathogens are encapsulated organisms (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae).
  3. Prophylaxis:
    • Ensure vaccination and antibiotic prophylaxis in all patients with hyposplenism.
  4. Complications:
    • Focus on OPSI as a medical emergency.
  5. Differentials:
    • Consider other causes of recurrent infections (e.g., primary immunodeficiencies).